Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
about
Intravenous and gastric cerium dioxide nanoparticle exposure disrupts microvascular smooth muscle signalingRegulation of cardiovascular cellular processes by S-nitrosylationVascular dysfunction in patients with chronic arsenosis can be reversed by reduction of arsenic exposureNitric oxide synthases, S-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities (review)Indices of oxidative stress in pregnancy with fetal growth restrictionImpairment of NO-dependent relaxation in intralobar pulmonary arteries: comparison of urban particulate matter and manufactured nanoparticlesThe roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunctionThe Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitusHypotensive effect of Gentiana floribunda is mediated through Ca++ antagonism pathwayGlycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatmentProtective effect of surfactant inhalation against warm ischemic injury in an isolated rat lung ventilation model.3',4'-Dihydroxyflavonol reduces infarct size and injury associated with myocardial ischaemia and reperfusion in sheep.Targeting gene therapy vectors to the vascular endothelium.Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression.Nanocarriers for nitric oxide delivery.Pharmacological induction of vascular extracellular superoxide dismutase expression in vivo.Impact of eNOS-Dependent Oxidative Stress on Endothelial Function and Neointima Formation.Cocoa and chocolate in human health and diseaseExercise and postprandial lipaemia: effects on peripheral vascular function, oxidative stress and gastrointestinal transit.Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effects.Leucine supplementation via drinking water reduces atherosclerotic lesions in apoE null mice.Hypertension and Estrogen Deficiency Augment Aneurysmal Remodeling in the Rabbit Circle of Willis in Response to Carotid Ligation.Intense exercise training is not effective to restore the endothelial NO-dependent relaxation in STZ-diabetic rat aorta.Nitric oxide homeostasis as a target for drug additives to cardioplegiaCerebral blood flow response to flavanol-rich cocoa in healthy elderly humansEffect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclaseDoes regular consumption of green tea influence expression of vascular endothelial growth factor and its receptor in aged rat erectile tissue? Possible implications for vasculogenic erectile dysfunction progression.Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration.Vascular nitric oxide: effects of exercise training in animalsInhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.Pros and cons of L-arginine supplementation in disease.Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases.Rocuronium Bromide Inhibits Inflammation and Pain by Suppressing Nitric Oxide Production and Enhancing Prostaglandin E2 Synthesis in Endothelial Cells.Nitric oxide protects the heart from ischemia-induced apoptosis and mitochondrial damage via protein kinase G mediated blockage of permeability transition and cytochrome c release.Characterization of the components of urban particulate matter mediating impairment of nitric oxide-dependent relaxation in intrapulmonary arteries.Sodium nitrite exerts an antihypertensive effect and improves endothelial function through activation of eNOS in the SHR.Locally different endothelial nitric oxide synthase protein levels in ascending aortic aneurysms of bicuspid and tricuspid aortic valve.Effects of nitroglycerin/L-cysteine on soluble guanylate cyclase: evidence for an activation/inactivation equilibrium controlled by nitric oxide binding and haem oxidation.Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2.
P2860
Q23923199-1E36DE2D-41C7-43D3-B2A1-A4D049B23798Q24300987-5CD6C309-B5D0-45F1-A093-1A4D20BFC051Q24811654-66770F95-592A-4C73-8285-867495115626Q26823520-BDACAEDF-0E9A-4703-81F2-554CD519FDEBQ28218877-7F196DA6-0088-4450-AA84-465F104EA3E8Q28386002-BEE36EB2-A8B4-4ADA-9DE7-A8C45548B28CQ28386344-9DA1F84F-F0D0-4D72-8E04-3FED43EEF8DCQ33392407-AE3589AE-ABD1-4DD7-AB85-05CF8A119BB3Q34375951-9DADA210-6911-45AE-A7E7-6E4570756E59Q34517974-616EE197-303C-49FC-8680-FEDAAD9B57E6Q34979574-AE385E9B-F3BD-4181-9384-4111397BFF70Q35047196-541DC9E1-58ED-479C-9C15-92FFA7738DDFQ35095393-115D0BCF-3461-4972-A837-D6527A717F0BQ35140371-CE8E978B-CD82-4577-8293-1514E6081B20Q35176430-12002512-50C3-4379-A202-EDC02A22B897Q35832084-9E43D2AF-4C3F-4D79-915E-588C7B5FA5B2Q36086630-82A68201-091A-4991-9359-DE215560EBB5Q36417456-8F529678-5FCF-4D5A-A882-6089E378E218Q36449444-1A08A5F0-0B80-4CC5-B021-73F8DE0414E5Q36543429-296F77EE-CA70-4195-A5FF-95B6D3A05B28Q36569766-2D5A431D-04EE-4628-932A-53605C5FD77DQ36579304-F7F53C48-BF71-4D00-8A83-1CC9D70D61BCQ36647049-BEA44405-B705-40BD-8DA9-6AF8921DF301Q36691194-A210A77D-09B0-46CF-BCA8-21F6F678619AQ36814343-76224101-C25A-4213-BFB8-2A2EFE6B519CQ36842153-ADEAA316-A8C1-44D5-8A6E-424414120472Q36938470-E8DF329B-2D81-4EED-B45F-38651A03E966Q36979390-F795FC37-9CD4-4BD5-849A-BE507B756E4AQ36980757-52ADEA3A-32D4-4162-B389-F213880204B3Q37106804-3A986829-E8B5-4521-A80D-96C75717B382Q37113619-4500C072-67C6-4FF7-B8A8-1A1062F3D66BQ37350078-F07AC4ED-4C0E-4FE6-B839-2EE0632297B7Q37439021-8CA3F18A-C1EF-4582-8A9E-ACAC822E2C0FQ38407116-09A4B0EE-7A4B-4EAF-8FB9-B38DD98985E6Q39390741-24A8B2BD-7B4D-4332-8308-22EBD7E6EF31Q40126457-8E8CD0A2-2232-4123-8E07-CA45FEA7841BQ41063658-DB5C4264-DBA3-432A-9141-081884B4C27DQ41879372-E6D8DB08-60E5-4B72-8068-F7E398DE640FQ42139185-FE888B7B-5078-4097-92A4-638810E60367Q42162039-FB87BE19-3216-44C1-ACA6-2F46DEEE63E8
P2860
Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
@ast
Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
@en
Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
@nl
type
label
Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
@ast
Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
@en
Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
@nl
prefLabel
Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
@ast
Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
@en
Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
@nl
P1476
Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
@en
P2093
Georg Kojda
Michael T Gewaltig
P304
P356
10.1016/S0008-6363(02)00327-9
P577
2002-08-01T00:00:00Z